Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Anticancer Research|July 7, 2021
Radiotherapy as Elective Treatment of the Node-negative Neck in Oral Squamous Cell CancerErik Lundin, Johan Reizenstein, Fredrik Landstrom, et al.
Nature Communications|April 7, 2022
Direct measurements of mRNA translation kinetics in living cellsMikhail Metelev, Erik Lundin, Ivan L Volkov, et al.
Plos One|July 7, 2018
Dissolved organic carbon in streams within a subarctic catchment analysed using a GIS/remote sensing approachPearl Mzobe, Martin Berggren, Petter Pilesjö, et al.
Frontiers in Microbiology|May 15, 2018
Genetic Adaptation to Growth Under Laboratory Conditions in Escherichia coli and Salmonella entericaAnna Knöppel, Michael Knopp, Lisa M Albrecht, et al.
Forensic Science International|November 7, 2007
15-Second conducted electrical weapon exposure does not cause core temperature elevation in non-environmentally stressed resting adultsDonald M Dawes, Jeffrey D Ho, Mark A Johnson, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II trialAndreas Hallqvist, Stefan Bergström, Hedvig Björkestrand, et al.
Environmental Science & Technology|March 15, 2022
Seasonal Fluctuations in Iron Cycling in Thawing Permafrost PeatlandsMonique S Patzner, Nora Kainz, Erik Lundin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2015
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trialBjörn Zackrisson, Elisabeth Kjellén, Karin Söderström, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 19, 2016
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow upJohanna Nyqvist, Per Fransson, Göran Laurell, et al.
BMC Cancer|March 26, 2026
Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095Karin Söderkvist, Maira Zia, Adalsteinn Gunnlaugsson, et al.
Pageof 3